← Back to Search

Procedure

SURE vs. Standard Ureteroscopy for Kidney Stones

N/A
Waitlist Available
Research Sponsored by Calyxo, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Presence of renal stone(s)
Candidate for ureteroscopy with laser lithotripsy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial will compare the two most common treatments for kidney stones.

Who is the study for?
This trial is for individuals who need treatment for kidney stones and are candidates for a procedure called ureteroscopy with laser lithotripsy. Participants must be able to attend all follow-up procedures, understand the study, and have signed consent. It's not open to pregnant people, those with a BMI over 45, significant other health issues, or abnormalities in the bladder, ureter or kidneys.Check my eligibility
What is being tested?
The study compares two methods of removing kidney stones: SURE (Steerable Ureteroscopic Renal Evacuation) versus standard basketing during ureteroscopy. The goal is to determine which method has better outcomes for patients.See study design
What are the potential side effects?
Potential side effects may include discomfort or pain from the procedure, bleeding, infection risk due to stone removal process and possible damage to urinary tract structures during intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have kidney stones.
Select...
I am a candidate for a procedure to remove kidney stones using lasers.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
SFR

Trial Design

2Treatment groups
Active Control
Group I: Standard Ureteroscopy (Basketing)Active Control1 Intervention
Group II: SUREActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Calyxo, Inc.Lead Sponsor

Media Library

Standard Ureteroscopy (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04519294 — N/A
Kidney Stones Research Study Groups: Standard Ureteroscopy (Basketing), SURE
Kidney Stones Clinical Trial 2023: Standard Ureteroscopy Highlights & Side Effects. Trial Name: NCT04519294 — N/A
Standard Ureteroscopy (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04519294 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the geographic range of this experiment?

"Albany Medical College in Albany, New york and Prisma Health in Greenville, South carolina are two of the primary clinical trial locations for this study. Duke University in Durham, North carolina is a third notable site along with 10 other medical centres."

Answered by AI

Does this trial permit those who are of legal age to participate?

"Consistent with the study's parameters, participants must be between 18 and 80 years old to qualify for inclusion."

Answered by AI

Who meets the criteria to participate in this research?

"This clinical trial is recruiting 162 individuals with urolithiasis between the ages of 18 and 80. To be eligible for enrolment, patients must exhibit a willingness to attend all follow-up visits required by the study protocol."

Answered by AI

How many participants are currently enrolled in this experiment?

"Calyxo, Inc. will oversee the execution of this trial across Albany Medical College and Prisma Health, both in need of 162 participants meeting predetermined inclusion criteria."

Answered by AI

Is enrollment in this trial open at this time?

"Affirmative. According to the information logged on clinicaltrials.gov, this trial is still in need of participants and was initially posted on June 16th 2021. As of November 10th 2022, 162 patients are required from a span of 10 medical sites."

Answered by AI
~40 spots leftby Apr 2025